Streptokinase Injection Stpase 1500000 IU

Blood clots that have developed in the blood arteries are broken up by the enzyme Streptokinase Injection. It is given as soon as heart attack symptoms appear to increase patient survival. Deep venous thrombosis and pulmonary embolism are two conditions that may be treated with this medication.

Each occluded limb of the cannula should be progressively infused with 2 mL of solution containing 250,000 IU Streptokinase. For two hours, clamp off the cannula limb(s). Keep a watchful eye on the patient to spot any potential side effects. Aspirate the contents of the infused cannula limb(s) after therapy, then flush with saline and reconnect the cannula.

Blood clots are made primarily of fibrin, which is broken down by the protein plásmin, which dissolves blood clots after they have stopped bleeding. Streptokinase-induced increased plasmin synthesis dissolves undesirable blood clots, such as those in the lungs (pulmonary embolism).

• Symptoms of Stpase INJ (150000IU)
• Bleeding is most frequent.
• Fever, shivering, breathing difficulties, asthma, rash, hives, itching, flushing, nausea,
• and headache are all allergic reactions.
• Depression in the respiratory system

Therefore, “accelerated” streptokinase administered over a 15-minute period to patients who had an acute myocardial infarction within the previous 12-hour period was well tolerated and led to better grades of TIMI flow in the infarct-related artery than the “standard” one-hour infusion regimen.

In contrast to the “standard” one-hour infusion protocol, “accelerated” streptokinase given over 15 minutes to patients who appear within 12 hours of an acute myocardial infarction is well tolerated and leads to higher grades of TIMI flow in the infarct-related artery.

Biofactor A 50-200 ml intravenous infusion of physiological saline, a 5 percent glucose solution, a 5 percent fructose solution, or a Ringer-lactate solution may be used to administer streptokinase.

a proteolytic enzyme generated by hemolytic streptococci that aids in the breakdown of blood clots by triggering the production of plasmin by activating plasminogen.

Streptokinase therapy should start as soon as possible, ideally within 7 days of the initiation of the thrombotic episode. To neutralise any potential anti-streptokinase antibodies, the loading dose is advised.

Check this Product Cardiac Adrenaline Tartrate 1mg/1ml Injection or you may explore more Cardiac by clicking here

We are an exporter from India and work in excess countries like the UAE , Oman, Qatar, Myanmar, Saudi Arabia, Netherland, Albania, Saint lucia , Jordan , Romania ,South africa , and so on.